 ROCHESTER, N.Y., Jan. 19, 2021 GLOBE NEWSWIRE -- Document Security Systems, Inc. DSS or the Company NYSE American: DSS, a multinational company operating businesses focusing on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, today announced its wholly owned subsidiary Impact BioMedical, Inc. Impact BioMedical entered into an investment and distribution agreement with Nano9 Labs, LLC Nano9, an RD and contract manufacturing company specializing in the development of nano-sized nutraceutical products and ingredients. 